Verzenio

Active Ingredient(s): Abemaciclib
FDA Approved: * September 28, 2017
Pharm Company: * ELI LILLY AND CO
Category: Cancer

Abemaciclib (trade names Verzenio, Verzenios and Ramiven) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[1] It was designated as a breakthrough therapy for breast cancer by the U.S. Food and Drug Administration (FDA) in October 2015.[2] On 28 September 2017, it was approved for use in the United States by the FDA for the treatment of certain breast ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Verzenio 50 mg Oral Tablet
NDC: 0002-4483
Labeler:
Eli Lilly and Company
Verzenio 100 mg Oral Tablet
NDC: 0002-4815
Labeler:
Eli Lilly and Company
Verzenio 150 mg Oral Tablet
NDC: 0002-5337
Labeler:
Eli Lilly and Company
Verzenio 200 mg Oral Tablet
NDC: 0002-6216
Labeler:
Eli Lilly and Company